Where HNW and Family Office Investors access exclusive Fund Opportunities
Exclusive access to VC, Digital Asset, Credit and Property related Opportunities – Deal with Managing Partners Direct
-
0
+
Investors & Deal Makers
-
0
Unicorns
-
0
Year track record
POWERED BY CapitalHQTM
Our proprietary AI-driven venture investment platform for Fund Managers, High-Net-Worth Investors and Family Offices
Personalised deal flow, streamlined information access and curated opportunities
BetterX
Paycepaid
QBiotics Group
Biosignals Diagnostics
SurgiBox Inc.
Access Exclusive Private Opportunities
Get access to leading emerging growth companies, private opportunities, alternative funds, venture investment education and exclusive investor events
- Free Account Set up
- No transaction fees
- Direct Access to CEOs
Paycepaid
BetterX
QBiotics Group
Biosignals Diagnostics
SurgiBox Inc.
A Personalised Pipeline of Opportunities
Let our AI/ML provide you with personalised, exclusive and consistent deal flow
BetterX
Paycepaid
QBiotics Group
Biosignals Diagnostics
SurgiBox Inc.
BetterX
- Overview
- Market Opportunity
- Competitive Advantage
- Highlights and Milestones
- Investment Offering
Streamlined Investor Experience
Access the information you want and need, in a structured, clear format.
Trusted by hundreds of companies worldwide
Our international clientele includes leading emerging growth companies, funds, governments, universities, incubators, accelerators and advisory firms.
As seen in
See more exiting opportunities on CapitalHQ
BetterX
BetterX offers B2B and B2B2C white-label and API driven software solutions to traditional institutions to offer digital asset services to their clients.
Paycepaid
Paycepaid is a Software as a Service debt collection solution unlike any on the market today with a heavy focus on the debtor. Empowering businesses to manage their end to end collections while providing debtors with a magnitude of options to reduce financial stress and anxiety.
Wholesale Investor
Wholesale Investor, with over 45,000 subscribers, is a leading private capital marketplace operating across Australia, Singapore, and the UK. It has a 15-year track record of connecting private market opportunities with HNW, professional, and family office investors. In just 4 years, our product…
PRIMAL ORGANIX
Primal Organix has created the world’s first botanically derived Terpene blended anti-anxiety health supplement that manages anxiety in minutes. Our purpose is to support positive mental ill-health and well-being in all human beings.
Sustainable Fintech Fund
Startupbootcamp, the #1 Accelerator in the world outside of the US, established in 2010, operates in 27 countries around the globe, has accelerated over 1600+ startups with a success rate of 76% remaining active, raised over $2.2B in total funding, a network of more than 300+ investors, 5000…
Misio
Sustainability performance and stakeholder communications are now fundamental to overall corporate profitability and impact. Misio simplifies a complex eco-system to help large & listed companies shift the sustainability narrative out from annual reports into easy to understand digital…
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,…
National Property Group
National Property Group (NPG) is a trusted alternative provider of property data and insights empowering informed decisions for all property market participants. NPG relaunched its property data & analytics intelligence platform in 2021, delivering instant insights from more than 40 years of…
Novapep
Novapep, an Australian/US biotech, has developed a patented peptide structure called biparediteTM as an oral inflammatory bowel disease therapy, which will be a cost effective first-in-class drug. Biparetide has been shown in animals to be as effective as expensive, injectable biologic drugs (a…
Backed By Leading Investment Groups and Family Offices
Backed By Leading Investment Groups and Family Offices